1 documents found
Information × Registration Number 0119U102904, R & D request Title Multicenter, randomized, double-blind, placebo-controlled, 12-week, parallel group study to evaluate the efficacy and safety of 2 fixed doses of MIN-101 as monotherapy for the treatment of adult patients with negative schizophrenia symptoms, followed by an additional 40-week open-label study Head Skripnikov Andriy M., Доктор медичних наук Registration Date 23-08-2019 Organization Ukrainian medical stomatological Academy popup.description1 Study of the efficacy and safety of 2 fixed doses of MIN-101 as monotherapy for the treatment of adult patients with negative schizophrenia symptoms, followed by a 40-week open-label additional study popup.nrat_date 2024-12-10 Close
search.res_rk
Multicenter, randomized, double-blind, placebo-controlled, 12-week, parallel group study to evaluate the efficacy and safety of 2 fixed doses of MIN-101 as monotherapy for the treatment of adult patients with negative schizophrenia symptoms, followed by an additional 40-week open-label study
Head: Skripnikov Andriy M.. Multicenter, randomized, double-blind, placebo-controlled, 12-week, parallel group study to evaluate the efficacy and safety of 2 fixed doses of MIN-101 as monotherapy for the treatment of adult patients with negative schizophrenia symptoms, followed by an additional 40-week open-label study. Ukrainian medical stomatological Academy. № 0119U102904
1 documents found

Updated: 2026-03-27


Роздрукувати цю сторінку